Quresh Khairullah

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

PK Judge, Natalie Staplin, KJ Mayne et al. · The Lancet Diabetes & Endocrinology · 2023 · 88 citations · Full text

Dialysate sodium delivery can alter chronic blood pressure management

Michael J. Flanigan, Quresh Khairullah, Victoria S. Lim · American Journal of Kidney Diseases · 1997 · 86 citations

Hypertension, Cardiovascular Disease, Sodium Homeostasis +8

Economic Evaluation of Urgent-Start Peritoneal Dialysis Versus Urgent-Start Hemodialysis in the United States

Frank Xiaoqing Liu, Arshia Ghaffari, Harman Dhatt et al. · Medicine · 2014 · 65 citations · Full text

Dialysis Therapy, Cost Model, United States +18

Comparison of Vancomycin versus Cefazolin as Initial Therapy for Peritonitis in Peritoneal Dialysis Patients

Quresh Khairullah, Robert Provenzano, Jukaku S. Tayeb et al. · Peritoneal Dialysis International · 2002 · 48 citations

Dialysis Therapy, Vancomycin Versus Cefazolin, Antimicrobial Stewardship +17

Effect of biocompatibility of hemodialysis membranes on serum albumin levels

Jukaku S. Tayeb, Robert Provenzano, Mohamed El-Ghoroury et al. · American Journal of Kidney Diseases · 2000 · 33 citations

Hemodialysis, Urology, Renal Function +7